Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: eico20 who wrote (1741)	3/8/2016 12:48:18 PM
From: mokelumne river	Read Replies (2) \| Respond to of 2026

How is it that Sandoz is becoming another Abbott for us? Sure, they are not as bad as Abbott, but Sandoz controls a much larger Vitaros market than Canada. To wit: Germany, Austria, Belgium, Luxemburg, the Netherlands, Denmark, Finland, Iceland, Norway, Sweden and Switzerland, Malaysia, Indonesia, the Philippines, Thailand, Taiwan, Vietnam, Hong Kong and Singapore. So a Sandoz slow up for whatever reason has a huge impact on the potential sales trajectory. What is particularly irritating is that Sandoz has aggressively tied up a lot of Vitaros marketing territory but has not aggressively marketed. Just what we don't need. Just venting.